SCHEMBL9380286

SCHEMBL9380286

Cc1nnc2n1-c1ccc(C#CCOc3ccccc3)cc1C(c1ccccc1Cl)=NC2

nearest known ligand 0.86

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PTAFR P25105 12/20 0.86
GABRA1 P14867 6/20 0.70
GABRA5 P31644 6/20 0.70
GABRA2 P47869 6/20 0.70
GABRB2 P47870 5/20 0.70
GABRA3 P34903 4/20 0.70
GABRG2 P18507 1/20 0.63
HTR2A P28223 1/20 0.63
GABRB3 P28472 1/20 0.63
ADRA1A P35348 1/20 0.63
OPRK1 P41145 1/20 0.63
PDE4D Q08499 1/20 0.63
TSHR P16473 1/20 0.61
HPGD P15428 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9378889 0.93 PTAFR (1.00) PTAFRGABRA1GABRA5GABRA2GABRB2
SCHEMBL9379179 0.88 PTAFR (0.70) PTAFRGABRA1GABRA5GABRA2GABRB2
SCHEMBL9378167 0.84 PTAFR (1.00) PTAFR
Hydrochloric Acid SCHEMBL9378428 0.83 PTAFR (0.98) PTAFR
SCHEMBL9379492 0.83 PTAFR (1.00) PTAFRGABRA1GABRA5GABRA2GABRB2
SCHEMBL7722603 0.83 GABRA1 (0.78) PTAFRGABRA1GABRA5GABRA2GABRB2
SCHEMBL7717650 0.83 GABRA1 (1.00) PTAFRGABRA1GABRA5GABRA2GABRB2
SCHEMBL3138147 0.82 GABRA1 (0.76) PTAFRGABRA1GABRA5GABRA2GABRB2
SCHEMBL9380367 0.81 PTAFR (0.73) PTAFRGABRA1GABRA5GABRA2GABRB2
SCHEMBL9382835 0.81 PTAFR (0.86) PTAFRGABRA1GABRA5GABRA2GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0320992-B1 Triazolodiazepine derivatives HOFFMANN LA ROCHE (CH) 1994-07-27 EP disclosed
US-4959361-A Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists HOFFMANN-LA ROCHE INC. (US) 1990-09-25 US disclosed